Which Hedge Funds Own BMRN — Biomarin Pharmaceutical Inc

19 of the hedge funds we track hold BMRN, worth $1.27B combined as of the Q2 2026 13F filings (preliminary, still landing).

Versus the prior quarter: 2 opened a new position, 5 added, 12 trimmed, 3 exited.

12 of those are hedged quant multi-strategy books, not directional conviction.

Insider buying at BMRN · All tracked funds